Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Frontiers in Pharmacology
|
March 29, 2021
Multi-Target Approaches in Metabolic Syndrome
Felix F Lillich, John D Imig, Ewgenij Proschak
Archiv Der Pharmazie
|
June 5, 2026
Silymarin and Its Isolated Flavanonol Lignans Are Liver X Receptor Antagonists
Nils C Bandomir, Astrid Kaiser, Felix F Lillich, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics
Simone Schierle, Apirat Chaikuad, Felix F Lillich, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 Agonists
Alisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Nature Communications
|
September 11, 2024
Automated design of multi-target ligands by generative deep learning
Laura Isigkeit, Tim Hörmann, Espen Schallmayer, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells
Steffen Brunst, Julia Schönfeld, Peter Breunig, et al.
Molecular Therapy. Nucleic Acids
|
March 1, 2022
DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells
Sandra Seredinski, Frederike Boos, Stefan Günther, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism
Sabine Willems, Romy Busch, Felix Nawa, et al.
Comprehensive Physiology
|
February 7, 2026
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension
Matthieu Leuillier, Mustapha Chelgham, Hind Messaoudi, et al.
Biochemical Pharmacology
|
September 28, 2016
Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazoles
Simon B M Kretschmer, Stefano Woltersdorf, Dominik Vogt, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Frontiers in Pharmacology
|
March 29, 2021
Multi-Target Approaches in Metabolic Syndrome
Felix F Lillich, John D Imig, Ewgenij Proschak
Archiv Der Pharmazie
|
June 5, 2026
Silymarin and Its Isolated Flavanonol Lignans Are Liver X Receptor Antagonists
Nils C Bandomir, Astrid Kaiser, Felix F Lillich, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics
Simone Schierle, Apirat Chaikuad, Felix F Lillich, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 Agonists
Alisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Nature Communications
|
September 11, 2024
Automated design of multi-target ligands by generative deep learning
Laura Isigkeit, Tim Hörmann, Espen Schallmayer, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells
Steffen Brunst, Julia Schönfeld, Peter Breunig, et al.
Molecular Therapy. Nucleic Acids
|
March 1, 2022
DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells
Sandra Seredinski, Frederike Boos, Stefan Günther, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism
Sabine Willems, Romy Busch, Felix Nawa, et al.
Comprehensive Physiology
|
February 7, 2026
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension
Matthieu Leuillier, Mustapha Chelgham, Hind Messaoudi, et al.
Biochemical Pharmacology
|
September 28, 2016
Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazoles
Simon B M Kretschmer, Stefano Woltersdorf, Dominik Vogt, et al.
Page
of 2